Recursion Pharmaceuticals Inc.

09/03/2025 | Press release | Archived content

Rising Leaders 2025: Daniel Cohen’s Transition From Grad To AI Pioneer In Drug Discovery

Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip

Rising Leaders 2025: Daniel Cohen's Transition From Grad To AI Pioneer In Drug Discovery

Sep 03 2025
• By David Wild
(Shutterstock)
Share current article via Email Share current article via Twitter Share current article via LinkedIn

Related Content

Will AI Expertise Push Canada Forward As A Biopharma Hub?

Jan 22 2024

Related Companies

Recursion Pharmaceuticals, Inc.

Valence Discovery

Additional Topics

Rising LeadersLeadershipArtificial IntelligenceInnovationCanadaResearch & Development

More from Rising Leaders

More from Leadership

Twitter feedRSS feedRSS feed
  • About UsOpens in new window
  • Meet the TeamOpens in new window
  • RSS FeedOpens in new window
  • Contact Us
  • Customer Service
  • Subscribe
  • AdvertisingOpens in new window
  • Feedback
HomeTerms and ConditionsOpens in new windowPrivacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.

Recursion Pharmaceuticals Inc. published this content on September 03, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 15, 2025 at 13:19 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]